Watson gains FDA approval for generic Plan B

06/24/2009 | Wall Street Journal, The

Watson Pharmaceuticals' generic version of the Plan B morning-after contraceptive pill received FDA approval for women 18 and older. The company plans to launch the nonprescription drug Aug. 24, when Duramed Pharmaceuticals' market exclusivity for Plan B expires. The generic version will be available for women 17 and younger by prescription only.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC